Evidence
Clin Neurol Neurosurg. 2024 Feb 9;238:108152. doi: 10.1016/j.clineuro.2024.108152. Online ahead of print.
ABSTRACT
OBJECTIVES AND AIMS: Neuromyelitis Optica Spectrum Disorder (NMOSD) is a disabling autoimmune disease of the central nervous system that requires immunosuppressants to control the relapses. The latter puts them at risk for more severe COVID-19 infection. Vaccines are an effective way to control the pandemic. However, we do not know how effective they are in immunologically compromised patients. We aimed to evaluate and compare antibody levels in NMOSD patients treated with disease-modifying therapies after two doses of inactivated and mRNA COVID-19 vaccines.
METHODS: Patients with NMOSD diagnosis and age-sex matched healthy controls who received two doses of either inactivated and mRNA COVID-19 vaccine were recruited in the study. Serum samples were collected at least two weeks after the second dose.
RESULTS: Serum samples from 24 NMOSD patients (Mean age-36.58, Female-70.83%) and 24 healthy controls (Mean age-36.71, Female-70.83%) were evaluated. Mean antibody titer was lower in the NMOSD group (Mean; SD (2.43 ± 1.51) than in healthy controls (Mean; SD 3.23 ± 0.80). Seronegativity was only seen in the rituximab group, there were no such cases in the azathioprine group. (9 vs 0).
CONCLUSIONS: The study shows that NMOSD patients treated with rituximab may still be susceptible to severe COVID-19 infection even after both inactivated and mRNA vaccines.
PMID:38382130 | DOI:10.1016/j.clineuro.2024.108152
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
COVID-19 vaccine response in Neuromyelitis Optica Spectrum Disorder
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Immunosuppressive therapy in elderly patients with neuromyelitis optica spectrum disorder: a retrospective multicentre study
- A Rare Post-Infectious Autoimmune Manifestation of COVID-19
- Central nervous system manifestations following vaccination against COVID-19
- The incidence of neurological complications in mechanically ventilated COVID-19 ICU patients: An observational single-center cohort study in three COVID-19 periods
- Ground-breaking study reveals how COVID-19 vaccines prevent severe disease
- Patients hospitalized with active tuberculosis and Covid-19 coinfection: A matched case-control from the Brazilian Covid-19 Registry
- A potential association between COVID-19 vaccination and development of alzheimer's disease
- Risk of COVID-19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric Disorders
- Post-COVID parkinsonism: A scoping review
- The impact of COVID-19 pandemic on women with endometriosis: a retrospective cohort study on referral center population
- COVID-19 in Individuals with Chronic Liver Diseases
- Letter: Chat-GPT on brain tumors: An examination of Artificial Intelligence/Machine Learning's ability to provide diagnoses and treatment plans for example neuro-oncology cases
- Polysomnography and Neuropsychological Analysis of Patients With Post-Traumatic Stress Disorder Two Years After the COVID-19 Pandemic in Wuhan
- Potential impact of annual vaccination with reformulated COVID-19 vaccines: Lessons from the US COVID-19 scenario modeling hub
- Association of Pulmonary Function Test Abnormalities and Quality-of-Life Measures after COVID-19 Infection
- Post-COVID-19 Suicide Note: A Case Report of Late Onset Catatonia
- Exploring the causal effects of depression and antidepressants on COVID-19
- Prospective and Cross-Sectional Factors Predicting Caregiver Motivation to Vaccinate Children with Attention-Deficit/Hyperactivity Disorder against COVID-19: A Follow-Up Study
- Prospective and Cross-Sectional Factors Predicting Caregiver Motivation to Vaccinate Children with Attention-Deficit/Hyperactivity Disorder against COVID-19: A Follow-Up Study
- Neuropsychiatric symptoms associated with the COVID-19 and its potential nervous system infection mechanism: the role of imaging in the study
- Impact of COVID-19 on posttraumatic stress disorder in ICU survivors: a prospective observational comparative cohort study
- Pyruvate dehydrogenase-E1a deficiency presenting as generalized dystonia: A genetic diagnosis with important clinical implications
- The COVID-19 Vaccine Safety Research Center: a cornerstone for strengthening safety evidence for COVID-19 vaccination in the Republic of Korea
- Clinical presentation of severe COVID‑19 with heart failure: A single‑center retrospective study
- Effects of Beliefs, Conspiracy Theories, and Vaccine Hesitancy on the Vaccination Status of Patients with Severe Mental Illness in a Tertiary Psychiatric Care Hospital in Türkiye
- Integrating the Patient's Voice into the Research Agenda for Treatment of Chemosensory Disorders
- The anxiety response of patients with severe psychiatric disorders to the recent public health crisis
- Vaccine value profile for Klebsiella pneumoniae
- New knowledge on anti-IgLON5 disease
- Causal Associations between Posttraumatic Stress Disorder and COVID-19
- Causal Associations between Posttraumatic Stress Disorder and COVID-19
- Causal Associations between Posttraumatic Stress Disorder and COVID-19
- Causal Associations between Posttraumatic Stress Disorder and COVID-19
- Reduction in presynaptic dopamine transporter may be associated with future problematic delusion
- Clinical characteristics and outcomes among hospitalised COVID-19 patients across epidemic waves in Spain: An unCoVer analysis
- Contingency management for substance use disorders in the U.S. Veterans Health Administration: 2018-2022
- Impact of dementia on 30-, 180-, and 365-day mortality during the first pandemic wave in older adults seen in spanish emergency departments diagnosed with or without COVID-19
- Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis
- Critical incidents in Colorado's opioid treatment programs: A comparison of the COVID-19 pandemic to previous years
- Cognitive function in Mexican older adults 6-months after recovering from SARS-CoV-2 infection
- Impact of COVID-19 Pandemic on Patients with Serious Mental Illness (SMI) and Nonpsychiatric Control Subjects in Clinical Trials
- Suicide mortality in Spain during the COVID-19 pandemic: Longitudinal analysis of sociodemographic factors
- Prognostic factors for disease activity in newly diagnosed teriflunomide-treated patients with multiple sclerosis: a nationwide Danish study
- The impact of the COVID-19 pandemic on perceptions of social relationships, negative affect, and paranoid ideation
- Predictors and Clinical Characteristics of Relapses in LGI1-Antibody Encephalitis
- French guidelines for the diagnosis and management of Tourette syndrome
- Which Factors Are Associated With Comorbid Psychiatric Conditions in Patients Affected by Substance Use Disorders? The Impact of COVID-19 Pandemic on Dual-Diagnosis Subjects
- Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021
- Potential Convergence of Olfactory Dysfunction in Parkinson's Disease and COVID-19: The Role of Neuroinflammation
- Pregnant women with COVID-19 ARDS on the intensive care unit
- Effect of Dialectical Behavior Therapy on Negative Affect, and Symptoms of Depression and Anxiety in Individuals with Borderline Personality Disorder during COVID-19 Pandemic
- Analysis of Antipsychotic Dosage in Patients With Tardive Dyskinesia: A Case-Control Study Using the Claims Database of the Corporate Health Insurance Association
- Features of olfactory impairment connected with trigeminal nerve system
- Dynamics of N6-methyladenosine modification during Alzheimer's disease development
- Phenotype clustering of hospitalized high-risk patients with COVID-19 - a machine learning approach within the multicentre, multinational PCHF-COVICAV registry
- Prevalence of autoimmune diseases in functional neurological disorder: influence of psychiatric comorbidities and biological sex
- Clinical Outcome in Persons with Severe Mental Disorders Attending a Mental Health Day Center during the COVID-19 Pandemic
- Capturing the emotional and social experiences of COVID-19 through journal entries: A qualitative study of COVID-19 experiences over six weeks following infection
- Innovative applications of artificial intelligence during the COVID-19 pandemic
- Pathogenesis and immunopathology of paraneoplastic disorders
- Smoking cessation among tuberculosis patients during the coronavirus disease-2019 pandemic
- Treatment adherence rates across different psychiatric disorders and settings: findings from a large patient cohort
- Associations of history of alcohol use disorder with loneliness, social support, and mental health during the COVID-19 pandemic
- Seroprevalence and sociodemographic characteristics of Toxoplasma gondii infection in patients with psychiatric disorders in Malaysia
Evidence Blueprint
COVID-19 vaccine response in Neuromyelitis Optica Spectrum Disorder
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
COVID-19 vaccine response in Neuromyelitis Optica Spectrum Disorder
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- COVID-19 vaccine response in Neuromyelitis Optica Spectrum Disorder
- Long-term disability progression in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a retrospective analysis of 101 patients
- Immunosuppressive therapy in elderly patients with neuromyelitis optica spectrum disorder: a retrospective multicentre study
- A Neuromyelitis Optica Spectrum Disorder (NMOSD) Genome-Wide association study gives new insights to a neuroinflammatory disease...
- MRI to differentiate multiple sclerosis, neuromyelitis optica, and myelin oligodendrocyte glycoprotein antibody disease
- Independent and reproducible hippocampal radiomics biomarkers for multisite multiple sclerosis and neuromyelitis optica spectrum disorders
- The association between body mass index, demographic and clinical characteristics with cognitive performance in patients with neuromyelitis optica spectrum disorder
- Neuromyelitis Optica Spectrum Disorder
- Non-demyelinating disorders mimicking and misdiagnosed as NMOSD, a literature review
- Prognostic factors of first-onset optic neuritis based on diagnostic criteria and antibody status: a multicentre analysis of 427 eyes
- Chloride intracellular channel protein-1 (CLIC1) antibody in multiple sclerosis patients with predominant optic nerve and spinal cord involvement
- B cells orchestrate tolerance to the neuromyelitis optica autoantigen AQP4
- Double hit - A case in point for dual seropositivity to AQP4 and MOG antibodies
- Investigation of sexual dysfunction and depression prevalence in neuromyelitis optica spectrum disorder
- Cladribine Tablets Mode of Action, Learning from the Pandemic: A Narrative Review
- Mixed-methods examination of attitudes and behaviors related to COVID-19 vaccines among parents of children with autism and autistic adults
- CD11chigh B Cell Expansion Is Associated With Severity and Brain Atrophy in Neuromyelitis Optica
- Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination
- mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses
- Anxiety, Optimism, and COVID-19 Vaccine Hesitancy among Students in a University in Southern Thailand during the 2021 Academic Year
- COVID-19 vaccines found to be effective in reducing long COVID symptoms
- Oxford launches new vaccine trial to enhance design of flu & COVID-19 vaccines
- Visualization and analysis of mapping knowledge domains for optic neuritis: a bibliometric research from 2013 to 2022
- Autonomic nervous system involvement in autoimmune encephalitis and paraneoplastic neurological syndromes
- Modeling how antibody responses may determine the efficacy of COVID-19 vaccines
- COVID-19 and influenza vaccine co-administration among older U.S. adults
- Emerging functions and therapeutic targets of IL-38 in central nervous system diseases
- Emerging functions and therapeutic targets of IL-38 in central nervous system diseases
- Vaccination and clozapine use: a systematic review and an analysis of the VAERS database
- Neutralizing antibody titers over 12 months after SARS-CoV-2 mRNA vaccine booster in patients with relapsing multiple sclerosis continuously treated with ofatumumab
- COVID-19 diagnostic testing and vaccinations among First Nations in Manitoba: A nations-based retrospective cohort study using linked administrative data, 2020-2021
- A Rare Post-Infectious Autoimmune Manifestation of COVID-19
- Flu-like syndrome due to interferon-beta injections does not increase anxiety, depression, and lost working days in multiple sclerosis patients during the Sars-CoV-2 pandemic
- Central nervous system manifestations following vaccination against COVID-19
- Ischemic stroke after COVID-19 bivalent vaccine administration in patients aged 65 years and older in the United States
- NEURO-COVAX: An Italian Population-Based Study of Neurological Complications after COVID-19 Vaccinations
- Predictors of Motivation to Receive a COVID-19 Vaccination and the Number of COVID-19 Vaccine Doses Received in Patients with Schizophrenia
- The incidence of neurological complications in mechanically ventilated COVID-19 ICU patients: An observational single-center cohort study in three COVID-19 periods
- Sjögren's Syndrome and Devic's Disease: A Synchronised Saga
- COVID-19 and Alzheimer's disease: Impact of lockdown and other restrictive measures during the COVID-19 pandemic
- The Second Dose of COVID-19 Vaccine Booster Hesitancy Among Healthcare Workers in China: A Multicenter Cross-sectional Study
- Ground-breaking study reveals how COVID-19 vaccines prevent severe disease
- Patients hospitalized with active tuberculosis and Covid-19 coinfection: A matched case-control from the Brazilian Covid-19 Registry
- A potential association between COVID-19 vaccination and development of alzheimer's disease
- Risk of COVID-19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric Disorders
- Post-COVID parkinsonism: A scoping review
- Fatigue Potentially Reduces the Effect of Transcranial Magnetic Stimulation on Depression Following COVID-19 and Its Vaccination
- Risk for diagnosis or treatment of mood or anxiety disorders in adults after SARS-CoV-2 infection, 2020-2022
- Impact of COVID-19 pandemic on mortality rate in memory clinic patients
- The impact of COVID-19 pandemic on women with endometriosis: a retrospective cohort study on referral center population
- Prenatal Exposure to COVID-19 mRNA Vaccine BNT162b2 Induces Autism-Like Behaviors in Male Neonatal Rats: Insights into WNT and BDNF Signaling Perturbations
- Efficacy and Safety of the Natural Killer T Cell-Stimulatory Glycolipid OCH-NCNP1 for Patients With Relapsing Multiple Sclerosis: Protocol for a Randomized Placebo-Controlled Clinical Trial
- An Observational Study of Multi-Faceted Demyelinating Disorders
- Neuropathological findings in COVID-19 vs. non-COVID-19 acute respiratory distress syndrome-A case-control study
- COVID-19 in Individuals with Chronic Liver Diseases
- Letter: Chat-GPT on brain tumors: An examination of Artificial Intelligence/Machine Learning's ability to provide diagnoses and treatment plans for example neuro-oncology cases
- Prevalence, pathogenesis and spectrum of neurological symptoms in COVID-19 and post-COVID-19 syndrome: a narrative review
- Complement dysregulation is a prevalent and therapeutically amenable feature of long COVID
- Polysomnography and Neuropsychological Analysis of Patients With Post-Traumatic Stress Disorder Two Years After the COVID-19 Pandemic in Wuhan
- Coping and risk perception during the COVID-19 pandemic in type 2 diabetes: Does it influence metabolic control?
- A review of the clinical progress on helminths and their derivative products in autoimmune disease
- Incident Ocular Inflammation After COVID-19 Infection in a US Veteran Population
- Life and disease status of patients with Parkinson's disease during and after zero-COVID in China: an online survey
- Compounding for the Treatment of COVID-19 and Long COVID, Part 4: The Legacy of Chronic COVID